A randomised, double blind, phase II clinical trial of maintenance cabozantinib following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS cabozantinib comparison
Jones, R. J. Hussain, S. A. Birtle, A. J. Song, Yee Pei Enting, D. Faust, G. Hilman, S. Jagdev, S. McGovern, U. B. Parikh, O.
Jones, R. J.
Hussain, S. A.
Birtle, A. J.
Song, Yee Pei
Enting, D.
Faust, G.
Hilman, S.
Jagdev, S.
McGovern, U. B.
Parikh, O.
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Jones RJ, Hussain SA, Birtle AJ, Song YP, Enting D, Faust G, et al. A randomised, double blind, phase II clinical trial of maintenance cabozantinib following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS cabozantinib comparison. Journal of Clinical Oncology. 2022 Jun;40(17). PubMed PMID: WOS:000891791500024.